Atherosclerotic Biomarkers and Aortic Atherosclerosis by Cardiovascular Magnetic Resonance Imaging in the Framingham Heart Study
View/ Open
Author
Hong, Susie N.
Gona, Philimon
Fontes, Joao D.
Oyama, Noriko
Kenchaiah, Satish
Yeon, Susan B.
Schnabel, Renate B.
Keaney, John F.
Benjamin, Emelia J.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1161/JAHA.113.000307Metadata
Show full item recordCitation
Hong, S. N., P. Gona, J. D. Fontes, N. Oyama, R. H. Chan, S. Kenchaiah, C. W. Tsao, et al. 2013. “Atherosclerotic Biomarkers and Aortic Atherosclerosis by Cardiovascular Magnetic Resonance Imaging in the Framingham Heart Study.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2 (6): e000307. doi:10.1161/JAHA.113.000307. http://dx.doi.org/10.1161/JAHA.113.000307.Abstract
Background: The relations between subclinical atherosclerosis and inflammatory biomarkers have generated intense interest but their significance remains unclear. We sought to determine the association between a panel of biomarkers and subclinical aortic atherosclerosis in a community‐based cohort. Methods and Results: We evaluated 1547 participants of the Framingham Heart Study Offspring cohort who attended the 7th examination cycle and underwent both cardiovascular magnetic resonance imaging (CMR) and assays for 10 biomarkers associated with atherosclerosis: high‐sensitivity C‐reactive protein, fibrinogen, intercellular adhesion molecule‐1, interleukin‐6, interleukin‐18, lipoprotein‐associated phospholipase‐A2 activity and mass, monocyte chemoattractant protein‐1, P‐selectin, and tumor necrosis factor receptor‐2. In logistic regression analysis, we found no significant association between the biomarker panel and the presence of aortic plaque (global P=0.53). Using Tobit regression with aortic plaque as a continuous variable, we noted a modest association between biomarker panel and aortic plaque volume in age‐ and sex‐adjusted analyses (P=0.003). However, this association was attenuated after further adjustment for clinical covariates (P=0.09). Conclusions: In our community‐based cohort, we found no significant association between our multibiomarker panel and aortic plaque. Our results underscore the strengths and limitations of the use of biomarkers for the identification of subclinical atherosclerosis and the importance of traditional risk factors.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886740/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879484
Collections
- HMS Scholarly Articles [17917]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)